Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Press Releases

Press Releases Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Criminal Investigations
          Press Releases
          October 11, 2016: Foreign National Pleads Guilty To International Wire Fraud SchemePress Releases October 11, 2016: Foreign National Pleads Guilty To International Wire Fraud Scheme
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOCI Small Clear Seal
			**Food and Drug Administration 
			Office of Criminal Investigations****U.S. Department of Justice Press Release**For Immediate Release
			October 11, 2016
			United States Department of Justice

			District of New Hampshire



CONCORD, N.H. –Mustafa Hasan Arif, an individual with dual citizenship in Pakistan and the United Kingdom, appeared in United States District Court in Concord, NH today where he pled guilty to wire fraud.  Arif defrauded individuals by fraudulently selling drugs claiming to cure many serious diseases.  Arif targeted individuals around the world, including victims in New Hampshire, announced United States Attorney Emily Rice.



According to court records, while in Lahore, Pakistan, Arif created, maintained and controlled over 1,500 websites that promoted the sale of drugs claiming to cure and treat hundreds of diseases, many of which were incurable, including cerebral palsy, mental retardation, Parkinson’s disease, Alzheimer’s disease, and emphysema.  The websites included falsified cure rates, false clinical research and fabricated testimonials.  One series of websites fraudulently claimed to have shown in clinical trials a cure rate of 90 percent, while other websites included links to clinical research that had not been written about the drugs on the websites. Arif falsely represented that the drugs were being sold by entities in Germany, Norway, Italy, Australia, New Zealand and Denmark when in fact the drugs were all being sold and shipped from Pakistan. Arif used those false addresses to make customers more comfortable purchasing the drugs. Documents in the case show that Arif ‘s scheme generated more than $12 million in fraudulent sales.



Arif was originally arrested on a criminal complaint issued in New Hampshire after he flew into New York in February 2014 on a business trip.  He appeared in federal court in New York and was transferred to New Hampshire, where he has remained in custody. Arif is scheduled to be sentenced on January 26, 2017.



This investigation was led by the FDA/Office of Criminal Investigations, Cybercrime Investigations Unit along with Homeland Security Investigations. Assistance during the investigation was provided by the New Hampshire Attorney General’s Office, Portsmouth New Hampshire Police Department, the United States Consulate, Diplomatic Security Service Lagos, Nigeria office, New Zealand Ministry of Health, United Kingdom Medicines and Healthcare Products Regulatory Agency, and the Department of Justice, Office of International Affairs.  The investigation is being prosecuted by Assistant United States Attorney Arnold H. Huftalen and Senior Counsel Sarah Hawkins of the FDA/Office of Chief Counsel.



###

USAO - New Hampshire



Topic:

Cyber Crime

                                                                                  Content current as of:
      01/16/2018Press Releases
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop